about
Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancerProperties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent.Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation.Chemistry-based functional proteomics for drug target deconvolution.Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.Anticancer drugs from traditional toxic Chinese medicines.Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism.Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts.The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species.Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines.Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide.How natural are 'natural herbal remedies'? A Saudi perspective.12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione.
P2860
Q33258696-EE4C0AE9-469D-4DCE-917E-ABE3C28C211FQ33717094-41FCCDA0-1B58-4674-991E-63ECEC1EBA1EQ34339982-980C1D7D-512A-405C-BF71-AA0DD8AA647BQ34342905-36CB3B6D-D88B-4F38-9D29-9E3749A5F237Q34757206-7DBA601A-8A61-4573-8FED-20DBE7906259Q35155855-7B3EAD3B-D639-47D6-B413-06C458879669Q36509566-F5AB5BE9-832B-4875-B20F-C37C86276726Q37990470-6B932A96-F93C-4D1E-989C-1CAD56F978E4Q40240010-3E542A66-1398-4CBE-B1B5-44B5DBB49E22Q40308578-F4592D92-EC47-4C4F-892B-ACB59FF406E2Q40373034-7CCCCA5F-F4A3-47D3-9627-3370D9562631Q40458332-721EE9B2-7F2C-4D9B-9C9C-852C05665EA3Q40574315-DEE5607D-8DDF-4BB8-8948-F478C49EE941Q42151417-112D3CEE-6F8F-4448-96F6-E7B338B0E95EQ44142876-DD50AC19-C3FF-47E8-9866-F172B94A6CE2Q44263109-88263A44-2A08-4AB3-98F2-E56FD15086D7Q44650493-6EF4A70B-139A-4735-B040-3DB76554CB2F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Arsenic compounds as anticancer agents.
@ast
Arsenic compounds as anticancer agents.
@en
Arsenic compounds as anticancer agents.
@nl
type
label
Arsenic compounds as anticancer agents.
@ast
Arsenic compounds as anticancer agents.
@en
Arsenic compounds as anticancer agents.
@nl
prefLabel
Arsenic compounds as anticancer agents.
@ast
Arsenic compounds as anticancer agents.
@en
Arsenic compounds as anticancer agents.
@nl
P356
P1476
Arsenic compounds as anticancer agents.
@en
P2093
P2888
P356
10.1007/S002800100309
P478
48 Suppl 1
P577
2001-08-01T00:00:00Z
P6179
1052448906